A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion

被引:40
作者
Cleveland, SM
McLain, L
Cheung, L
Jones, TD
Hollier, M
Dimmock, NJ [1 ]
机构
[1] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England
[2] Axis Genet, Cambridge CB2 4AZ, England
关键词
D O I
10.1099/vir.0.18630-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The similar to150 amino acid C-terminal tail of the gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 (HIV-1) is generally thought to be located inside the virion. However, we show here that both monoclonal IgG and polyclonal epitope-purified IgG specific for the (746)ERDRD(750) epitope that lies within the C-terminal tail neutralized infectious virus. IgG was mapped to the C-terminal tail by its failure to neutralize tail-deleted virus, and by sequencing of antibody-escape mutants. The fact that antibody does not cross lipid membranes, and infectious virus is by definition intact, suggested that ERDRD was exposed on the surface of the virion. This was confirmed by reacting virus and IgG, separating virus and unbound IgG by centrifugation, and showing that virus was neutralized to essentially the same extent as virus that had been in constant contact with antibody. Epitope exposure on virions was independent of temperature and therefore constitutive. Monoclonal antibodies specific to epitopes PDRPEG and IEEE, upstream of ERDRD, also bound to virions, suggesting that they too were located externally. Protease digestion destroyed the ERDRD and PDRPEG epitopes, consistent with their proposed external location. Altogether these data are consistent with part of the C-terminal tail of gp41 being exposed on the outside of the virion. Possible models of the structure of the gp41 tail, taking these observations into account, are discussed.
引用
收藏
页码:591 / 602
页数:12
相关论文
共 85 条
[1]   EPITOPE MAPPING AND TOPOLOGY OF BACULOVIRUS-EXPRESSED HIV-1 GP160 DETERMINED WITH A PANEL OF MURINE MONOCLONAL-ANTIBODIES [J].
ABACIOGLU, YH ;
FOUTS, TR ;
LAMAN, JD ;
CLAASSEN, E ;
PINCUS, SH ;
MOORE, JP ;
ROBY, CA ;
KAMINLEWIS, R ;
LEWIS, GK .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) :371-381
[2]   MEMBRANE PERMEABILIZATION BY DIFFERENT REGIONS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMEMBRANE GLYCOPROTEIN GP41 [J].
ARROYO, J ;
BOCETA, M ;
GONZALEZ, ME ;
MICHEL, M ;
CARRASCO, L .
JOURNAL OF VIROLOGY, 1995, 69 (07) :4095-4102
[3]   Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins [J].
Berlioz-Torrent, C ;
Shacklett, BL ;
Erdtmann, L ;
Delamarre, L ;
Bouchaert, I ;
Sonigo, P ;
Dokhelar, MC ;
Benarous, R .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1350-1361
[4]   TRIMERIC SUBDOMAIN OF THE SIMIAN IMMUNODEFICIENCY VIRUS GLYCOPROTEIN [J].
BLACKLOW, SC ;
LU, M ;
KIM, P .
BIOCHEMISTRY, 1995, 34 (46) :14955-14962
[5]   UNUSUAL FEATURES OF PROTEIN-INTERACTION IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) VIRIONS [J].
BUKRINSKAYA, AG ;
SHAROVA, NK .
ARCHIVES OF VIROLOGY, 1990, 110 (3-4) :287-293
[6]   A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE [J].
Buratti, E ;
Tisminetzky, SG ;
DAgaro, P ;
Baralle, FE .
JOURNAL OF VIROLOGY, 1997, 71 (03) :2457-2462
[7]   Conformational display of two neutralizing epitopes of HIV-1 gp41 on the Flock House virus capsid protein [J].
Buratti, E ;
Tisminetzky, SG ;
Scodeller, ES ;
Baralle, FE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 197 (1-2) :7-18
[8]   The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope [J].
Buratti, E ;
McLain, L ;
Tisminetzky, S ;
Cleveland, SM ;
Dimmock, NJ ;
Baralle, FE .
JOURNAL OF GENERAL VIROLOGY, 1998, 79 :2709-2716
[9]   EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY [J].
BURTON, DR ;
PYATI, J ;
KODURI, R ;
SHARP, SJ ;
THORNTON, GB ;
PARREN, PWHI ;
SAWYER, LSW ;
HENDRY, RM ;
DUNLOP, N ;
NARA, PL ;
LAMACCHIA, M ;
GARRATTY, E ;
STIEHM, ER ;
BRYSON, YJ ;
CAO, YZ ;
MOORE, JP ;
HO, DD ;
BARBAS, CF .
SCIENCE, 1994, 266 (5187) :1024-1027
[10]   A vaccine for HIV type 1: The antibody perspective [J].
Burton, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10018-10023